Biopharmaceutical company developing the first pharmacologic therapy for limbal stem cell deficiency and corneal wounds using topical formulations.
Trade on Claris Bio
Claris Bio shares
No active listings yet.
Be the first to post →Biopharmaceutical company developing the first pharmacologic therapy for limbal stem cell deficiency and corneal wounds using topical formulations.
Trade on Claris Bio
Claris Bio shares
No active listings yet.
Be the first to post →